Search

Your search keyword '"Sanda, Takaomi"' showing total 559 results
Start Over Author "Sanda, Takaomi"
559 results on '"Sanda, Takaomi"'

5. Clinical landscape of TP73 structural variants in ATL patients

Author

Hiramatsu, Hiroaki, Yokomori, Rui, Shengyi, Liu, Tanaka, Norio, Mori, Seiichi, Kiyotani, Kazuma, Gotoh, Osamu, Kusumoto, Shigeru, Nakano, Nobuaki, Suehiro, Youko, Ito, Asahi, Choi, Ilseung, Ohtsuka, Eiichi, Hidaka, Michihiro, Nosaka, Kisato, Yoshimitsu, Makoto, Imaizumi, Yoshitaka, Iida, Shinsuke, Utsunomiya, Atae, Noda, Tetsuo, Nishikawa, Hiroyoshi, Ueda, Ryuzo, Sanda, Takaomi, and Ishida, Takashi

Published
2023
Full Text
View/download PDF

10. Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia

Author

Suske, Tobias, Sorger, Helena, Manhart, Gabriele, Ruge, Frank, Prutsch, Nicole, Zimmerman, Mark W., Eder, Thomas, Abdallah, Diaaeldin I., Maurer, Barbara, Wagner, Christina, Schonefeldt, Susann, Spirk, Katrin, Pichler, Alexander, Pemovska, Tea, Schweicker, Carmen, Poloske, Daniel, Hubanic, Emina, Jungherz, Dennis, Muller, Tony Andreas, Aung, Myint Myat Khine, Orlova, Anna, Pham, Ha Thi Thanh, Zimmel, Kerstin, Krausgruber, Thomas, Bock, Christoph, Muller, Mathias, Dahlhoff, Maik, Boersma, Auke, Rulicke, Thomas, Fleck, Roman, de Araujo, Elvin Dominic, Gunning, Patrick Thomas, Aittokallio, Tero, Mustjoki, Satu, Sanda, Takaomi, Hartmann, Sylvia, Grebien, Florian, Hoermann, Gregor, Haferlach, Torsten, Staber, Philipp Bernhard, Neubauer, Heidi Anne, Look, Alfred Thomas, Herling, Marco, and Moriggl, Richard

Subjects
Tyrosine -- Comparative analysis -- Genetic aspects, T cells -- Comparative analysis -- Genetic aspects, Genes -- Comparative analysis -- Genetic aspects, Acute lymphocytic leukemia -- Development and progression -- Genetic aspects, Health care industry
Abstract

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive immature T cell cancer. Mutations in IL7R have been analyzed genetically, but downstream effector functions such as STAT5A and STAT5B hyperactivation are poorly understood. Here, we studied the most frequent and clinically challenging [STAT5B.sup.N642H] driver in T cell development and immature T cell cancer onset and compared it with STAT5A hyperactive variants in transgenic mice. Enhanced STAT5 activity caused disrupted T cell development and promoted an early T cell progenitor-ALL phenotype, with upregulation of genes involved in T cell receptor (TCR) signaling, even in absence of surface TCR. Importantly, TCR pathway genes were overexpressed in human T-ALL and mature T cell cancers and activation of TCR pathway kinases was STAT5 dependent. We confirmed STAT5 binding to these genes using ChIP-Seq analysis in human T-ALL cells, which were sensitive to pharmacologic inhibition by dual STAT3/5 degraders or ZAP70 tyrosine kinase blockers in vitro and in vivo. We provide genetic and biochemical proof that STAT5A and STAT5B hyperactivation can initiate T-ALL through TCR pathway hijacking and suggest similar mechanisms for other T cell cancers. Thus, STAT5 or TCR component blockade are targeted therapy options, particularly in patients with chemoresistant clones carrying [STAT5B.sup.N642H]., Introduction Acute lymphoblastic leukemia (ALL) is subdivided into B and T cell acute lymphoblastic leukemia (T-ALL), of which T-ALL represents up to 15% of pediatric and 25% of adult ALL [...]

Published
2024
Full Text
View/download PDF

17. T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation

Author

Feng, Hui, primary, Stachura, David L., additional, White, Richard M., additional, Gutierrez, Alejandro, additional, Zhang, Lu, additional, Sanda, Takaomi, additional, Jette, Cicely A., additional, Testa, Joseph R., additional, Neuberg, Donna S., additional, Langenau, David M., additional, Kutok, Jeffery L., additional, Zon, Leonard I., additional, Traver, David, additional, Fleming, Mark D., additional, Kanki, John P., additional, and Look, A. Thomas, additional

Published
2024
Full Text
View/download PDF

22. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1mRNA nuclear export in leukemia cells

Author

Terasaki, Tatsuya, Semba, Yuichiro, Sasaki, Kensuke, Imanaga, Hiroshi, Setoguchi, Kiyoko, Yamauchi, Takuji, Hirabayashi, Shigeki, Nakao, Fumihiko, Akahane, Koshi, Inukai, Takeshi, Sanda, Takaomi, Akashi, Koichi, and Maeda, Takahiro

Abstract

Selinexor, a first-in-class exportin1 (XPO1) inhibitor, is an attractive anti-tumor agent because of its unique mechanisms of action; however, its dose-dependent toxicity and lack of biomarkers preclude its wide use in clinical applications. To identify key molecules/pathways regulating selinexor sensitivity, we performed genome-wide CRISPR/Cas9 dropout screens using two B-ALL lines. We identified, for the first time, that paralogous DDX19A and DDX19B RNA helicases modulate selinexor sensitivity by regulating MCL1mRNA nuclear export. While single depletion of either DDX19Aor DDX19Bbarely altered MCL1 protein levels, depletion of both significantly attenuated MCL1mRNA nuclear export, reducing MCL1 protein levels. Importantly, combining selinexor treatment with depletion of either DDX19Aor DDX19Bmarkedly induced intrinsic apoptosis of leukemia cells, an effect rescued by MCL1 overexpression. Analysis of Depmap datasets indicated that a subset of T-ALL lines expresses minimal DDX19BmRNA levels. Moreover, we found that either selinexor treatment or DDX19Adepletion effectively induced apoptosis of T-ALL lines expressing low DDX19B levels. We conclude that XPO1 and DDX19A/B coordinately regulate cellular MCL1 levels and propose that DDX19A/B could serve as biomarkers for selinexor treatment. Moreover, pharmacological targeting of DDX19 paralogs may represent a potential strategy to induce intrinsic apoptosis in leukemia cells.

Published
2024
Full Text
View/download PDF

23. Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

Author

Prutsch, Nicole, Gurnhofer, Elisabeth, Suske, Tobias, Liang, Huan Chang, Schlederer, Michaela, Roos, Simone, Wu, Lawren C., Simonitsch-Klupp, Ingrid, Alvarez-Hernandez, Andrea, Kornauth, Christoph, Leone, Dario A., Svinka, Jasmin, Eferl, Robert, Limberger, Tanja, Aufinger, Astrid, Shirsath, Nitesh, Wolf, Peter, Hielscher, Thomas, Sternberg, Christina, Aberger, Fritz, Schmoellerl, Johannes, Stoiber, Dagmar, Strobl, Birgit, Jäger, Ulrich, Staber, Philipp B., Grebien, Florian, Moriggl, Richard, Müller, Mathias, Inghirami, Giorgio G., Sanda, Takaomi, Look, A. Thomas, Turner, Suzanne D., Kenner, Lukas, and Merkel, Olaf

Published
2019
Full Text
View/download PDF

31. Supplementary Table 5 from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Table 1 from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 4 from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 2 from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

35. Data from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Table 3 from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Materials and Methods from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figures from Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Author

Jia, Yunlu, primary, Zhou, Jianbiao, primary, Tan, Tze King, primary, Chung, Tae-Hoon, primary, Chen, Yongxia, primary, Chooi, Jing-Yuan, primary, Sanda, Takaomi, primary, Fullwood, Melissa J., primary, Xiong, Sinan, primary, Toh, Sabrina H.M., primary, Balan, Kalpnaa, primary, Wong, Regina W.J., primary, Lim, Julia S.L., primary, Zhang, Enfan, primary, Cai, Zhen, primary, Shen, Peng, primary, and Chng, Wee Joo, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 9 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Table I from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

Author

Weisberg, Ellen, primary, Halilovic, Ensar, primary, Cooke, Vesselina G., primary, Nonami, Atsushi, primary, Ren, Tao, primary, Sanda, Takaomi, primary, Simkin, Irene, primary, Yuan, Jing, primary, Antonakos, Brandon, primary, Barys, Louise, primary, Ito, Moriko, primary, Stone, Richard, primary, Galinsky, Ilene, primary, Cowens, Kristen, primary, Nelson, Erik, primary, Sattler, Martin, primary, Jeay, Sebastien, primary, Wuerthner, Jens U., primary, McDonough, Sean M., primary, Wiesmann, Marion, primary, and Griffin, James D., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure 1 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

42. Supplementary Figures 1-7 from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

Author

Weisberg, Ellen, primary, Halilovic, Ensar, primary, Cooke, Vesselina G., primary, Nonami, Atsushi, primary, Ren, Tao, primary, Sanda, Takaomi, primary, Simkin, Irene, primary, Yuan, Jing, primary, Antonakos, Brandon, primary, Barys, Louise, primary, Ito, Moriko, primary, Stone, Richard, primary, Galinsky, Ilene, primary, Cowens, Kristen, primary, Nelson, Erik, primary, Sattler, Martin, primary, Jeay, Sebastien, primary, Wuerthner, Jens U., primary, McDonough, Sean M., primary, Wiesmann, Marion, primary, and Griffin, James D., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Figure 8 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Figure 2 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure 6 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

46. Data from Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

Author

Weisberg, Ellen, primary, Halilovic, Ensar, primary, Cooke, Vesselina G., primary, Nonami, Atsushi, primary, Ren, Tao, primary, Sanda, Takaomi, primary, Simkin, Irene, primary, Yuan, Jing, primary, Antonakos, Brandon, primary, Barys, Louise, primary, Ito, Moriko, primary, Stone, Richard, primary, Galinsky, Ilene, primary, Cowens, Kristen, primary, Nelson, Erik, primary, Sattler, Martin, primary, Jeay, Sebastien, primary, Wuerthner, Jens U., primary, McDonough, Sean M., primary, Wiesmann, Marion, primary, and Griffin, James D., primary

Published
2023
Full Text
View/download PDF

47. Supplementary Figure Legend and Methods from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table 5 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Figure 3 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure 7 from TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia

Author

Sanda, Takaomi, primary, Tyner, Jeffrey W., primary, Gutierrez, Alejandro, primary, Ngo, Vu N., primary, Glover, Jason, primary, Chang, Bill H., primary, Yost, Arla, primary, Ma, Wenxue, primary, Fleischman, Angela G., primary, Zhou, Wenjun, primary, Yang, Yandan, primary, Kleppe, Maria, primary, Ahn, Yebin, primary, Tatarek, Jessica, primary, Kelliher, Michelle A., primary, Neuberg, Donna S., primary, Levine, Ross L., primary, Moriggl, Richard, primary, Müller, Mathias, primary, Gray, Nathanael S., primary, Jamieson, Catriona H.M., primary, Weng, Andrew P., primary, Staudt, Louis M., primary, Druker, Brian J., primary, and Look, A. Thomas, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results